This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Artificial intelligence (AI) can determine the course and severity of Merkel cell carcinomas (MCC), enhancing clinical decision making, a new study suggests. For the study, researchers combined machine learning with clinical expertise to develop a web-based system called DeepMerkel which offers the power to predict MCC treatment-specific outcomes based on personal and tumour specific features.
Incoming Intercoiffure President Scott Buchanan outlines his goals for the prestigious association and appoints Sonya Dove as its newest artistic director.
Double-sided stations and a compact footprint help a California salon maximize revenue potential with 40 stations, six treatment rooms and a nail area. But it's Salon Midori's modern, industrial and organic vibe that helped it snag a Salon of Distinction award in our Salons of the Year competition.
Christine Valmy, owner and operator of renowned educational institutions in the field of beauty, including the first and longest-running esthetics school in the nation, announced the launch of a new course: Barbering.
Christine Valmy, owner and operator of renowned educational institutions in the field of beauty, including the first and longest-running esthetics school in the nation, announced the launch of a new course: Barbering.
DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.
The activity of macrophages may be used to predict whether a melanoma patient will respond to immunotherapy, according to a study in JCO Oncology Advances. For the study, researchers examined novel biomarkers that may identify melanoma patients more likely to respond to talimogene laherparepvec (TVEC). TVEC is a modified oncolytic virus that is injected into melanoma directly to stimulate an immune response.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
36 
Let's personalize your content